Benitec Biopharma (BNTC) Other Accumulated Expenses (2019 - 2025)

Benitec Biopharma has disclosed Other Accumulated Expenses across 7 years of filings, most recently posting $62000.0 for Q4 2025.

• Other Accumulated Expenses for Q4 2025 came in at $62000.0, down 32.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $62000.0 (down 32.61% YoY), and the FY2025 annual result was $67000.0, down 51.45% from the prior year.
• Other Accumulated Expenses came in at $62000.0 for Q4 2025 at Benitec Biopharma, down from $147000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $223000.0 in Q4 2021 to a low of $36000.0 in Q1 2023.
• The 5-year median for Other Accumulated Expenses is $76500.0 (2023), against an average of $96050.0.
• Across the five-year window, Other Accumulated Expenses slumped 81.61% in 2022 and jumped 149.15% in 2025, its largest moves.
• Benitec Biopharma's Other Accumulated Expenses stood at $223000.0 in 2021, then plunged by 81.61% to $41000.0 in 2022, then surged by 80.49% to $74000.0 in 2023, then climbed by 24.32% to $92000.0 in 2024, then plunged by 32.61% to $62000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $62000.0 (Q4 2025), $147000.0 (Q3 2025), and $67000.0 (Q2 2025), per Business Quant data.